This submission is the product of wide collaboration, consultation, and consensus between a broad range of stakeholders, including genetic health professionals, researchers, consumer support groups, health and financial services advocacy organisations, professional member organisations and others. The submission represents broad community views, beyond the organisations which contributed to the original A-GLIMMER study.
